Fact-checked by Grok 2 weeks ago

Jackson Laboratory

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution specializing in genetics, genomics, and computational biology to address human diseases such as cancer, Alzheimer's, and diabetes. Founded in 1929 by geneticist Clarence C. Little in Bar Harbor, Maine, to investigate the genetic basis of cancer, JAX maintains a mission to discover precise genomic solutions for disease and empower the global biomedical community in improving human health. JAX pioneered the development of inbred mouse strains, establishing standardized genetic models that revolutionized biomedical research by enabling reproducible studies of hereditary diseases and treatments. The institution supplies over 2,300 distinct mouse strains and stocks to more than 2,000 organizations across 64 countries annually, supporting advancements linked to over 26 Nobel Prizes in Physiology or Medicine. With campuses in Bar Harbor, Farmington (Connecticut) for genomic medicine, and Sacramento (California) for computational resources, JAX integrates mouse genetics, human genomics, and data-driven modeling to translate basic research into clinical applications, while providing educational programs and resources to train the next generation of scientists.

Founding and Early History

Establishment by C.C. Little

The Jackson Laboratory was founded in 1929 by geneticist Clarence Cook Little in Bar Harbor, Maine, as an independent nonprofit institution dedicated to exploring the genetic foundations of diseases, especially cancer, through mammalian research. Little, a Harvard-educated biologist who had served as president of the University of Maine from 1922 to 1925 and the University of Michigan from 1925 to 1929, drew on his prior work in mouse genetics to establish the lab as a center for hereditary studies. Initial support came from private philanthropy, including contributions from the Ford, Webber, and Jackson families of Detroit, enabling Little to relocate his summer research operations from the University of Maine to a permanent facility on Mount Desert Island. Originally named the Roscoe B. Jackson Memorial Laboratory in recognition of automotive executive Roscoe B. Jackson, a key donor from the Hudson Motor Car Corporation, the institution operated without early commercial aims, focusing instead on fundamental scientific inquiry. Little's motivations stemmed from his conviction that cancer susceptibility involved heritable factors, which he aimed to isolate using controlled animal models rather than human subjects alone. From the outset, the laboratory emphasized breeding inbred mouse strains—genetically homogeneous lines achieved through brother-sister matings over multiple generations—to enable precise investigations of inheritance and disease traits. Little himself contributed to early strain development, including precursors to the widely used C57BL line first inbred in the 1920s, laying the groundwork for standardized models in genetics research. This approach positioned the Jackson Laboratory as a pioneer in mammalian genetics, prioritizing empirical reproducibility over applied or profit-driven outcomes.

Initial Focus on Mammalian Genetics

The Jackson Laboratory, founded in 1929 by geneticist Clarence C. Little, directed its initial efforts toward advancing mammalian genetics through systematic mouse breeding, emphasizing inbred strains to eliminate genetic heterogeneity in experimental models. Little, building on his pre-laboratory work—such as initiating the dilute brown non-agouti (DBA) strain in 1909 and precursors to the C57BL line in 1921 from breeder Abby Lathrop's stock—established the facility to produce and maintain these lines under controlled conditions. Inbreeding via brother-sister matings over multiple generations achieved homozygosity at most loci, reducing variability that confounded prior studies and enabling precise replication of phenotypes in biomedical research. This approach stemmed from first-principles recognition that genetic uniformity was essential for causal inference in inheritance and disease modeling. Central to this focus were applications in , where inbred strains facilitated tumor transplantation studies by permitting reliable graft survival within syngeneic s, unlike outbred populations prone to rejection. In , laboratory researchers, including Little and John J. Bittner, investigated transplantation success rates in hybrids and inbreds, revealing genetic barriers to tumor propagation and patterns of linked to host . These experiments demonstrated that tumors from donor mice of matching inbred backgrounds could be serially passaged indefinitely, providing a proxy for dissecting mammalian and cancer —insights unattainable with heterogeneous stocks. Such work underscored the strains' utility in probing causal genetic factors in , independent of environmental confounders. By the early 1940s, the laboratory had solidified its role as a primary distributor of these standardized strains, shipping live breeding pairs to academic and medical institutions across the United States to support independent replication and collaborative genetic inquiries. This dissemination, initiated shortly after founding, positioned Jackson as an indispensable repository, with strains like C57BL formalized through ongoing inbreeding protocols that ensured genetic stability for downstream applications in inheritance studies. Early recipients leveraged these resources for experiments on traits such as coat color, tumor susceptibility, and reproductive patterns, fostering a network of standardized mammalian models that accelerated progress in genetics prior to broader institutional expansions.

Institutional Development

The 1947 Morrell Park Fire and Recovery

On October 23, 1947, a massive wildfire known as the Great Fire of 1947 swept through Mount Desert Island, directly engulfing and destroying most facilities of The Jackson Laboratory in Bar Harbor, Maine. Driven by 40-mile-per-hour winds, the blaze originated from multiple ignition points amid dry conditions and consumed over 17,000 acres across the region, reaching the laboratory during its rapid southward advance toward Otter Point. The fire obliterated key laboratory buildings, including specialized mouse housing areas, resulting in the deaths of approximately 90,000 research mice essential for genetic studies, along with the complete loss of the institution's library and irreplaceable scientific records. No laboratory staff fatalities were recorded, though the overall fire claimed 14 human lives in Bar Harbor and surrounding areas, primarily from direct burns or related heart attacks. The destruction halted ongoing mammalian genetics research, which had been central to the lab's early mission, and threatened global supplies of inbred mouse strains used in biomedical experimentation. Immediate recovery was bolstered by philanthropic and governmental support, including grants totaling $955,000 from the Rockefeller Foundation and the National Cancer Institute, which funded debris clearance and new construction. By August 1949, the laboratory had completed initial rebuilding phases, erecting modern facilities to replace the gutted structures and restore operational capacity. Researchers from other institutions contributed by sharing mouse stocks to repopulate colonies, preventing a prolonged shortage of genetic models. In the long term, the catastrophe accelerated institutional reforms, including the diversification of mouse breeding programs across multiple strains and locations to reduce vulnerability to single-site disasters, as well as the adoption of stricter genetic archiving protocols for data and live specimens. These measures enhanced resilience, informing future expansions and contributing to the lab's evolution into a more distributed research entity by the 1950s.

Establishment of the Cancer Center

The Jackson Laboratory's focus on cancer genetics, integral to its mission since founding in 1929, laid the groundwork for its dedicated cancer research arm, which received formal National Cancer Institute (NCI) designation as a Basic Cancer Center in 1983—one of only seven such centers at the time. This recognition validated JAX's emphasis on mammalian genetics, particularly through inbred mouse strains that enabled controlled studies of hereditary cancer susceptibility, distinguishing genetic from environmental or infectious causes. By the late 1970s, intensified grant pursuits and collaborative basic research efforts positioned JAX for this milestone, underscoring the causal role of germline mutations in oncogenesis as demonstrated in mouse models. Early advancements using these models included the 1933 identification of a non-chromosomal factor influencing mammary tumor incidence in mice, later traced to a milk-transmitted virus, which provided foundational evidence for viral contributions to oncogene activation and tumor initiation. JAX researchers leveraged such strains to model and dissect key pathways, including the functional validation of tumor suppressor genes like Cdkn2a (encoding p16^INK4a^ and p19^Arf^), whose inactivation in engineered mice recapitulated tumor progression observed in human leukemias and solid tumors, informing targeted therapies that inhibit downstream effectors. These models established causal links by allowing precise genetic perturbations, revealing how loss-of-function mutations in suppressors like Tp53 or Rb1—first characterized through murine crosses—drive clonal expansion and metastasis, directly influencing clinical strategies for cancers such as retinoblastoma and acute myeloid leukemia. Post-2003 Human Genome Project, JAX integrated comparative genomics to bridge mouse models with human oncology, enhancing precision medicine by mapping orthologous variants and epigenetic modifiers across species. This evolution supported NCI renewals, including in 2020 for a five-year Cancer Center Support Grant, with ongoing evaluations affirming model-driven discoveries like genomic instability signatures predictive of therapy response in breast and brain cancers. Such work prioritizes verifiable genetic mechanisms over speculative interventions, using population-based mouse resources like the Collaborative Cross to quantify heritability and penetrance in multifactorial cancers.

Expansion to Multiple Campuses

The Jackson Laboratory expanded its operations beyond the Bar Harbor, Maine, campus with the establishment of a West Coast facility in Sacramento, California, initially opened in 2001 to support regional biomedical research, including production and distribution of mouse models relevant to metabolic disease studies. This site enhanced access for California-based researchers, enabling specialized services such as cryopreservation and breeding tailored to metabolic and related genetic investigations. In 2014, the institution opened the Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, a 183,500-square-foot facility adjacent to the University of Connecticut Health Center, dedicated to human genomics and precision medicine applications. This campus complemented the Bar Harbor focus on mammalian genetics by emphasizing computational genomics, single-cell sequencing, and clinical translation, with infrastructure supporting over 200 researchers. The October 2025 acquisition of the New York Stem Cell Foundation integrated stem cell research and high-throughput platforms into JAX operations, adding facilities in New York City for advanced iPSC-derived models and AI-enhanced predictive biology. These multi-campus developments strategically positioned the laboratory near diverse collaborators, such as UConn Health and West Coast biotech hubs, while distributing research across geographies to buffer against site-specific disruptions like the 1947 Bar Harbor fire.

Research Programs

Core Research Areas

The Jackson Laboratory conducts research primarily in genomics, cancer, immunology and autoimmunity (encompassing diabetes and lupus), aging, and neurodegeneration, utilizing mouse models to identify genetic mechanisms driving disease pathogenesis and inform precision interventions. These efforts integrate mammalian genetics with human genomic data to map causal variants and pathways, emphasizing empirical validation through controlled breeding and phenotyping of strains like the non-obese diabetic (NOD) mouse for type 1 diabetes or amyloid precursor protein models for Alzheimer's disease. Cancer investigations center on genomic alterations promoting tumor initiation, progression, and resistance, including the role of cancer stem cells in sustaining heterogeneity and evading therapies such as immunotherapy; studies demonstrate that these cells, distinct from bulk tumor populations, primarily determine resistance mechanisms via pathways like Wnt signaling in breast cancer models. The JAX Cancer Center employs patient-derived xenografts and genetic engineering to dissect aging-related inflammation's contributions to oncogenesis, prioritizing verifiable tumor suppressor and oncogene interactions over unproven environmental correlations. In immunology and autoimmunity, research elucidates polygenic risk factors and immune dysregulation, as in type 1 diabetes where NOD mouse strains reveal genetic loci influencing beta-cell destruction and interactions with viral triggers like endogenous retroviruses, enabling targeted validation of modifiers such as CRISPR-edited variants. Lupus studies leverage spontaneous models like MRL/MpJ-Fas^lpr^ to quantify T-cell and B-cell contributions to nephritis and autoantibody production, supporting efficacy testing of immunomodulators without reliance on anecdotal clinical extrapolations. Aging and neurodegeneration programs apply systems genomics to dissect proteostasis failure and neuronal loss, with the Center for Aging Research probing longevity pathways via caloric restriction mimetics in diverse strains, while the Center for Alzheimer's and Dementia Research advances humanized models incorporating APOE alleles and tau pathology to replicate sporadic disease trajectories more accurately than prior transgenic lines. Emerging humanized mouse platforms bridge species gaps by engrafting human immune components, facilitating causal inference in complex traits like immune senescence.

Genetic Resources and Mouse Models

The Jackson Laboratory maintains an extensive repository of over 11,000 genetically defined mouse strains, including inbred, congenic, and CRISPR/Cas9-edited models, which serve as standardized tools for biomedical research. These strains are cryopreserved or held in live breeding colonies to ensure genetic stability and uniformity, enabling reproducible experimental outcomes across laboratories by minimizing genetic drift and variability inherent in non-standardized animals. CRISPR-edited models, generated through services that introduce precise knockouts, knock-ins, or point mutations, facilitate targeted studies of gene function and disease mechanisms, with JAX having produced hundreds of such lines since adopting the technology in the mid-2010s. Distribution occurs via JAX Mice & Services, which supplies these strains to researchers worldwide, supporting consistent access to high-quality, pathogen-free models that underpin causal investigations into human diseases. International partnerships with distributors ensure delivery to regions including Europe, Asia, and beyond, with strains shipped live, cryopreserved embryos, or as sperm to accommodate global demand while preserving genetic integrity. This commercial distribution model necessitates rigorous quality control, including genetic monitoring and health surveillance, to provide models free of adventitious pathogens, thereby enhancing the reliability of downstream phenotyping and therapeutic testing. Key repositories, such as the Mouse Mutant Resource (MMR), focus on characterizing spontaneous and induced mutations through comprehensive genetic, genomic, and phenotypic analyses, making data publicly available to link variants to observable traits and disease phenotypes. Phenotyping pipelines in the MMR involve standardized assays for morphology, behavior, metabolism, and immunology, generating datasets that reveal causal relationships between mutations and physiological outcomes, independent of environmental confounders. By archiving and sharing these resources, JAX enables hypothesis-driven research that prioritizes empirical validation over anecdotal models, countering variability in ad-hoc breeding that can obscure true genetic effects.

Operations and Growth

Acquisitions and Partnerships

In October 2021, The Jackson Laboratory acquired the Research Models & Services business of Charles River Laboratories Japan as a wholly owned subsidiary for approximately $63 million. This transaction incorporated established facilities for producing and distributing genetically engineered mouse models, enhancing production capacity and providing direct market access in Asia, where demand for such resources supports regional biomedical research. In October 2025, The Jackson Laboratory completed its acquisition of the New York Stem Cell Foundation Research Institute. This integration added NYSCF's capabilities in human induced pluripotent stem cell (iPSC) derivation, robotic automation for high-throughput cell production, and AI-enabled analysis of large-scale patient-derived datasets, enabling combined use with JAX's mouse genetics platforms for modeling human disease heterogeneity and validating therapeutic responses. In March 2024, The Jackson Laboratory established a partnership with LG AI Research to develop AI models for genomic data analysis and disease prediction. The collaboration leverages JAX's repositories of mouse model phenotypes and genetic variants alongside LG's AI frameworks to simulate disease progression in conditions such as Alzheimer's and cancer, aiming to improve diagnostic accuracy and treatment forecasting through shared datasets while retaining institutional control over derived intellectual property.

Facilities and Global Reach

The Jackson Laboratory's primary facility is its headquarters campus in Bar Harbor, Maine, established in 1929 as the Jackson Laboratory for Mammalian Genetics, which serves as the core hub for mammalian genetics research and mouse production. This campus, spanning multiple sites including Ellsworth (opened in 2018 for expanded access), Augusta, and Portland, employs approximately 1,450 staff in Bar Harbor alone, contributing to the organization's total workforce of nearly 3,000 employees across all locations. Additional U.S. campuses include the Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, focused on human genomics and situated adjacent to the University of Connecticut Health Center on a 16-acre site, and a facility in Sacramento, California. Internationally, the organization expanded through the 2021 acquisition of Charles River Laboratories Japan's Research Models and Services business, establishing Jackson Laboratory Japan as a wholly owned subsidiary with about 250 employees operating production sites in Atsugi, Hino, and Tsukuba. The laboratory maintains a extensive global distribution network for its JAX® Mice, supplying over 13,000 genetically specialized strains to more than 2,400 organizations across 68 countries, supported by dedicated ground shipping in North America and air transport with international distributors for overseas delivery. Complementing this, the Mouse Genome Informatics (MGI) database, hosted by Jackson Laboratory, provides free worldwide access to integrated genetic, genomic, and biological data on the laboratory mouse, facilitating global research collaboration. Amid 2025 regulatory and funding pressures, including proposed National Institutes of Health (NIH) cuts that could eliminate up to $60 million annually in research support and a policy shift away from funding animal-only studies, the laboratory has pursued adaptations such as diversified revenue strategies and operational efficiencies to sustain its infrastructure and output. These measures build on prior expansions, ensuring continued scalability despite reliance on NIH grants totaling nearly $82 million from 106 awards in recent fiscal assessments.

Funding and Economic Model

Revenue Streams and Nonprofit Status

The Jackson Laboratory operates as a 501(c)(3) tax-exempt nonprofit organization, enabling it to reinvest all net revenues into its mission of advancing biomedical research without distributing profits to shareholders. This status, recognized by the IRS since its founding, supports a model that prioritizes scientific discovery over commercial gain, though it must navigate funding volatility in a field dominated by public grants. In fiscal year 2023, JAX reported operational revenue of $620 million, diversified across multiple streams to ensure sustainability. The largest portion, approximately $477 million or 77%, derived from sales of genetically engineered mice, cryopreserved embryos, and related research services provided to academic, pharmaceutical, and government clients worldwide. Government grants and contracts contributed $112 million, with the National Institutes of Health (NIH) as the primary federal funder; JAX secured record-level NIH awards in 2024 amid broader research funding trends. Philanthropic contributions and other sources, including investments, accounted for the remainder, underscoring a balanced approach that mitigates reliance on taxpayer-funded grants alone. This revenue mix facilitates operational resilience in a competitive landscape, where commercial genetic resources generate steady income to offset fluctuations in grant availability—for instance, JAX's grants fell 30% to $103 million in 2023 following pandemic-era peaks. As a nonprofit, JAX channels surplus funds into expanding facilities, researcher salaries, and technology transfer, fostering economic multipliers such as over 3,000 jobs and licensing agreements that stimulate local innovation ecosystems in Maine and beyond. This structure contrasts with for-profit biotech firms by emphasizing public benefit, though it requires vigilant adaptation to policy shifts, including proposed NIH budget cuts in 2025 that could impact up to 60% of its federal support.

Financial Challenges and Adaptations

The Jackson Laboratory's heavy reliance on federal grants, particularly from the National Institutes of Health (NIH), exposes it to substantial fiscal vulnerabilities, as NIH funding accounts for approximately $100 million annually—nearly all of its research support. Proposed fiscal year 2026 budget reductions, including a 40% cut to NIH appropriations, could eliminate $60 million per year for the institution, compounded by a 15% cap on indirect cost reimbursements for overhead such as lab facilities and supplies. These pressures, articulated by CEO Lon Cardon as threatening the "state of science in America," necessitate rapid operational adjustments to maintain research continuity. In response, the Laboratory has implemented cost efficiencies, including curtailed travel and conference spending while preserving employment levels, alongside optimized breeding protocols for mouse models to reduce colony maintenance expenses and animal usage through streamlined production frameworks. Diversification efforts emphasize private-sector engagement, such as expanded pharmaceutical services, philanthropic appeals, and partnerships like the merger with the New York Stem Cell Foundation to fuse genomics expertise with stem cell and AI capabilities for therapeutic development. Intellectual property strategies have also intensified, yielding a record 30 patents granted to 46 inventors in 2024 to enable licensing revenue. Such adaptations have underpinned output resilience, with the institution publishing 385 research papers and preprints in 2024—the highest annual total—and securing an "exceptional" rating, the top designation, on its National Cancer Institute Cancer Center Support Grant renewal, marking its strongest score since 1983. Overall grant funding rose 6.7% to $122.5 million, reflecting effective mitigation of domestic funding fluctuations through these multifaceted responses.

Scientific Contributions

Notable Researchers

George Snell, a Jackson Laboratory staff geneticist from 1935 to 1973, received the 1980 Nobel Prize in Physiology or Medicine, shared with Jean Dausset and Baruj Benacerraf, for discoveries elucidating genetically determined structures on mammalian cell surfaces that regulate immunological reactions, enabling advancements in tissue transplantation compatibility. Douglas L. Coleman, a professor at the laboratory from 1961 until his death in 2014, identified the ob/ob mouse mutation causing obesity and diabetes due to leptin deficiency, demonstrating a hormonal basis for appetite and energy balance regulation; this work, building on earlier mouse model studies, earned him the 2010 Albert Lasker Award for Basic Medical Research, shared with Jeffrey Friedman. Beverly Paigen, a senior research scientist from 1977 to her retirement, pioneered quantitative trait locus (QTL) analysis in mice to dissect complex traits like lipid metabolism; her group's 2005 identification of the Ath1 locus on chromosome 10, which modulates susceptibility to high-fat diet-induced atherosclerosis, provided empirical evidence for polygenic influences on cardiovascular disease risk. Bo Chang, a research scientist specializing in ocular genetics, has developed and characterized over 200 mouse strains with mutations causing retinal degenerations, including models for retinitis pigmentosa and achromatopsia, enabling precise phenotyping of photoreceptor dysfunction and gene therapy validation as of 2025. Gary Churchill, a professor focused on systems genetics, has advanced high-throughput phenotyping pipelines for mapping genetic variants to metabolic and behavioral traits in diverse mouse populations, with his 2024 International Mammalian Genome Society recognition honoring contributions to integrating genomic data with environmental factors for causal inference in complex diseases.

Key Achievements and Breakthroughs

The Jackson Laboratory pioneered the establishment of laboratory mice as primary models for human genetic diseases, particularly cancer, beginning with its founding in 1929 to investigate the genetic basis of tumors. This work laid the groundwork for using mice to proxy human conditions, including breakthroughs in leukemia research where JAX scientists identified nongenetic drivers of drug resistance and molecular RNA switches enabling chemoresistance in acute myeloid leukemia, informing targeted therapies. In Alzheimer's genetics, JAX advanced mouse modeling through the MODEL-AD consortium, developing strains mimicking late-onset susceptibility and producing the first comprehensive ranking of all known disease-associated genes and proteins by causal significance as of July 2024. These efforts elucidated genetic influences on neurodegeneration, linking retinal aging variants to brain health risks. Genomically, JAX maintains the Mouse Genome Informatics database, integrating data on genes, phenotypes, and expressions to support human analogs, and contributed to the Knockout Mouse Project by generating knockouts for thousands of genes to probe disease functions. By 2024, the institution secured its highest-ever annual grant funding, published 385 peer-reviewed papers, and obtained new patents, bolstering precision medicine via synthetic DNA switches for cell-specific gene control and enhanced next-generation sequencing pipelines. Despite these causal insights into genetic mechanisms, mouse models exhibit translational limitations, with genomic responses often failing to replicate human inflammatory dynamics or complex disease progression, as evidenced by discrepancies in preclinical versus clinical outcomes. JAX addresses this by emphasizing diverse strains to better predict human variability.

Controversies and Criticisms

Animal Welfare and Ethical Concerns

The Jackson Laboratory, as one of the world's largest breeders of genetically engineered mice for biomedical research, maintains production colonies that distribute millions of rodents annually, contributing significantly to the estimated 111 million mice and rats used in U.S. laboratories each year. Animal rights organizations, particularly People for the Ethical Treatment of Animals (PETA), have documented alleged welfare lapses, including a 2017 complaint citing mice left for days in wet shipping boxes leading to drowning and hypothermia, as well as improper handling by technicians resulting in injuries and deaths from dehydration or starvation. These claims draw from federal records spanning 2006 to 2016 revealing repeat violations of guidelines, such as inadequate monitoring and sanitation failures, though PETA's advocacy-oriented perspective warrants scrutiny for potential emphasis on emotive narratives over isolated incidents. More recent whistleblower reports, including a 2024 PETA-obtained account from a former employee, described noncompliance with protocols causing animal suffering, such as tumors going untreated and euthanasia delays during NIH-funded experiments on mice models for diseases like COVID-19 and cancer. A 2014 Maine court case involving technician Jessica Caruso highlighted internal retaliation against reports of mishandling, including mice frozen alive or subjected to extreme temperatures, underscoring tensions between staff oversight and operational pressures. Critics argue these patterns reflect systemic issues in high-volume breeding, where rapid production prioritizes quantity over individual welfare, fueling calls from animal rights groups for reduced reliance on rodents and greater adoption of non-animal alternatives like organoids or computational simulations. In response, Jackson Laboratory has denied PETA's core allegations, asserting that isolated errors are addressed through internal investigations and do not represent standard practices, while emphasizing its AAALAC-accredited Animal Health Program, which includes rigorous diagnostics, veterinary care, and pathology monitoring to minimize distress. The facility operates under U.S. Department of Agriculture (USDA) oversight via the Animal Welfare Act, requiring semiannual Institutional Animal Care and Use Committee (IACUC) inspections, though broader critiques note reduced federal scrutiny for accredited labs since 2019, potentially limiting transparency. Proponents of the laboratory's model counter that mouse-based research is indispensable for causal insights into human biology, enabling breakthroughs in therapies—such as monoclonal antibodies and gene therapies—that have saved millions of lives, with in silico or cell-based alternatives insufficient for validating complex physiological mechanisms empirically. This tension pits ethical imperatives to reduce animal numbers against evidence that refined models accelerate translational medicine, with ongoing refinements like enriched housing and analgesia protocols reflecting post-incident welfare enhancements at JAX.

Intellectual Property Disputes

In 2017, The Jackson Laboratory filed a federal complaint in the U.S. District Court in Maine against Nanjing University and its affiliated Model Animal Research Center and GEMM Bank of Model Animal, alleging breach of material transfer agreements (MTAs) governing the distribution of proprietary mouse strains. The complaint centered on unauthorized breeding and commercial sale of progeny from two strains—C57BL/6J and NOD.CB17-Prkdcscid/J (SCID)—provided under MTAs that explicitly prohibit resale, commercial breeding, or distribution beyond internal research use to safeguard intellectual property developed through substantial R&D investment. Jackson Laboratory sought to compel arbitration as stipulated in the agreements after unsuccessful attempts at resolution. The case was dismissed in April 2018 after Nanjing University agreed to proceed with arbitration, enabling Jackson Laboratory to enforce the contractual terms without prolonged litigation and underscoring risks of IP misappropriation in international collaborations, particularly amid reports of systematic technology transfer pressures from entities in China. This action exemplified Jackson Laboratory's vigilance against free-riding, where unauthorized commercialization erodes incentives for nonprofits to maintain and distribute specialized genetic resources costing millions in development and upkeep. Jackson Laboratory's IP framework includes patents on novel mouse strains, genetic modifications, and research methods—such as U.S. Patent 10,701,911 for NSG complement mice—and strict licensing via MTAs and limited-use agreements to restrict propagation and ensure attribution. These measures counter dilution of proprietary advances by open-access advocates, preserving revenue from controlled distribution that funds ongoing innovation in genomic medicine while deterring global replication without reciprocity. Successful enforcements like the Nanjing arbitration reinforce biotech property rights, balancing accessibility for research with economic sustainability against competitive threats.

Historical Ties to Eugenics

Clarence C. Little, founder of The Jackson Laboratory in 1929, was a prominent advocate for eugenics during the 1920s and 1930s, viewing it as a scientific approach to human genetic improvement through selective breeding and population control measures. As president of the American Eugenics Society from 1928 to 1938 and an officer in related organizations, Little promoted policies aimed at enhancing hereditary traits in humans, aligning with the era's mainstream scientific consensus that genetics dominated traits like intelligence and disease susceptibility, often downplaying environmental factors. This perspective influenced his establishment of the laboratory in Bar Harbor, Maine, initially to develop inbred mouse strains for studying mammalian genetics, which he believed could inform broader hereditary principles applicable to human populations. However, the laboratory's core mission centered on empirical genetic research using mice for medical applications, such as cancer susceptibility models, rather than direct implementation of eugenic policies for humans. Little's development of the first inbred mouse strains in the 1910s and 1920s provided reproducible genetic tools that enabled precise experimentation, yielding verifiable advancements in understanding gene-environment interactions and transplant rejection—contributions that persisted independently of eugenics' later discreditation due to methodological flaws, including overreliance on simplistic heritability estimates that ignored phenotypic plasticity and nurture effects demonstrated in subsequent twin and adoption studies. In July 2020, The Jackson Laboratory announced the removal of Little's name from its C.C. Little Conference Center, citing his eugenics advocacy as incompatible with contemporary values, while affirming repudiation of eugenics as a "thoroughly discredited" pseudoscience marred by ethical abuses and scientific invalidity. The institution emphasized that its ongoing work in genomic medicine and disease modeling derives from Little's foundational mouse genetics techniques, which have been empirically validated through decades of peer-reviewed research yielding tools like the DBA strain for leukemia studies, distinct from the flawed extrapolations to human societal engineering that undermined eugenics.

References

  1. [1]
    About JAX - The Jackson Laboratory
    The Jackson Laboratory is an independent, nonprofit biomedical research organization that leverages a unique combination of research, education and resources.Maine · Connecticut · Sacramento, California Campus · Board of Trustees
  2. [2]
    Cancer Research at JAX - The Jackson Laboratory
    C.C. Little established The Jackson Laboratory in 1929 to prove cancer is genetic, not infectious. He was right, of course, but little did he know that ...Missing: founded | Show results with:founded
  3. [3]
    JAX® Mice & Services - The Jackson Laboratory
    Access over 14,000 strains from our extensive repository or collaborate with our experts to develop a custom model designed to match your research needs.Find Lab Mice · Colony Management Services · Preclinical Research Services
  4. [4]
    The Jackson Laboratory | Molecular Medicine - BioMed Central
    Founded in 1929 in Bar Harbor, Maine, The Jackson Laboratory is a not-for-profit, independent research institution dedicated to the study of mammalian genetics.
  5. [5]
    Jackson Laboratory | Bar Harbor, ME - Official Website
    Its mission is to discover precise genomic ... In January 2013, JAX broke ground on the Jackson Laboratory for Genomic Medicine in Farmington, Connecticut.
  6. [6]
    History of The JAX Cancer Center - The Jackson Laboratory
    The Jackson Laboratory was founded in 1929 as one of the world's first centers for the study of cancer genetics. The independent, nonprofit laboratory has ...Missing: Little | Show results with:Little
  7. [7]
    Clarence Cook Little - Office of the President - The University of Maine
    Clarence Cook Little ... C.C. Little, a Harvard-trained scientist and researcher who went on to found the prestigious Jackson Laboratory in Bar Harbor, is ...Missing: founded | Show results with:founded
  8. [8]
    Clarence Cook Little papers, 1924-1929 - Finding Aids
    Following is tenure at Michigan, Little served as director of the Jackson Memorial Laboratory, 1929-1956 (emeritus director 1956-1971). Little died December 22, ...
  9. [9]
    [PDF] Clarence Cook Little Papers (1888-1971)
    The Joan Staats Library at The Jackson Laboratory is in the process of acquiring the complete bibliography of C.C. Little. Inventory: BOX 28: SERIES I. F1- ...
  10. [10]
    Auditorium honoring Jackson Laboratory founder C.C. Little to be ...
    The Jackson Laboratory was founded in 1929 by geneticist Clarence Cook Little and named for donor Roscoe Jackson.
  11. [11]
    Origins of Inbred Mice - Mouse Genome Informatics
    My assignment is to tell you about Prexy's contributions to inbred strains of mice, not to give you the entire history of The Jackson Laboratory, though the two ...
  12. [12]
    Profile: C57BL/6J - The Jackson Laboratory
    But has anyone wondered why this particular mouse, first bred in 1921 by Jackson Laboratory founder C.C. Little, has been so popular or acquired its name?
  13. [13]
    The use of mice in genetics, history and timeline
    Nov 3, 2014 · The first inbred mouse strain created by Little was the DBA (dilute brown non-agouti) mouse in 1909. In 1921 he bred the C57BL/6 strain, which ...<|separator|>
  14. [14]
    The History of Black 6 Mice | Charles River Laboratories
    Aug 18, 2021 · 1951: First black 6 substrain created from stock bought from The Jackson Laboratory by the US National Institutes of Health (NIH). The original ...
  15. [15]
    [PDF] George D. Snell - Nobel Lecture
    Little became interested in this subject as a graduate student at Harvard because of experiments with tumor transplants in mice carried out by Tyzzer at the ...
  16. [16]
    A genetic study of the transplantation of tumors arising in hybrid mice.
    Recommended Citation. Bittner JJ. A genetic study of the transplantation of tumors arising in hybrid mice. Am J Cancer 1931;15:2202-47.
  17. [17]
    [PDF] On October 23, 1947, fourteen people and tens of thou
    Focusing primarily on the inbred mice produced by one institution—the. Jackson Lab—my story chronicles both the specific evolution of one ani- mal species (mus ...
  18. [18]
    Fire of 1947 - Acadia National Park (U.S. National Park Service)
    Sep 1, 2020 · From Bar Harbor, the blaze raced down the coast almost to Otter Point, engulfing and destroying the Jackson Laboratory on its way. The fire blew ...Missing: Morrell | Show results with:Morrell
  19. [19]
    The Chemical News Parade | C&EN Global Enterprise
    It also marked the recovery from the fire of 1947 which almost completely destroyed the buildings, all of the 90,000 research mice, the library, as well as ...
  20. [20]
    RESEARCH CENTER GETS NEW HOUSING; Jackson Laboratory ...
    In the 1947 fire buildings, animal stocks and many precious records were lost. Grants totaling $955,000 from the Rockefeller Foundation, the National Cancer ...Missing: Morrell | Show results with:Morrell
  21. [21]
    A Mouse Chronology | Science
    A fire destroys most of The Jackson Lab and its mice. Researchers rally to rebuild stocks. Late 1940s George Snell develops congenic strains of mice—identical ...<|control11|><|separator|>
  22. [22]
    Essential Types of Mice in Short Supply : Lab Fire Taking Toll on ...
    May 29, 1989 · Those reserves were put in place after the last major fire at Jackson, in 1947. There are other places that breed mice for laboratory ...
  23. [23]
    The JAX Cancer Center - The Jackson Laboratory
    The Jackson Laboratory (JAX) was established in 1929 with a mission to unravel the intricate genetics of cancer, develop precise models of the disease and ...Missing: founded | Show results with:founded
  24. [24]
    The Jackson Laboratory Cancer Center - NCI
    Mar 20, 2025 · JAXCC is an independent, nonprofit biomedical research institution established in 1929 under the then-novel premise that cancer is a genetic disease.Missing: history | Show results with:history
  25. [25]
    C57BL/6-Cdkn2a em2Cjs /J - The Jackson Laboratory
    Dec 4, 2018 · The mouse Cdkn2a gene encodes two tumor suppressor proteins, p16Ink4a and p19Arf. Moreover, the Cdkn2a-encoded alternative reading frame ...
  26. [26]
    Genetically Engineered Mouse Models in Cancer Research - PMC
    Mouse models help understand tumor development, control mutation timing/location, study microenvironment, and test hypotheses in vivo.
  27. [27]
    National Cancer Institute Renews Jackson Laboratory's Cancer ...
    May 12, 2020 · National Cancer Institute Renews Jackson Laboratory's Cancer Center Designation. Article | May 12, 2020 barharbor_nw5a8545. liu-tall. Edison T ...Missing: date | Show results with:date
  28. [28]
    JAX celebrates a year of important achievements in genetics ...
    Feb 3, 2025 · The Jackson Laboratory (JAX) achieved groundbreaking scientific milestones in 2024, securing record grant funding, publishing 385 research ...
  29. [29]
    JAX expands its California presence | Mainebiz.biz
    May 1, 2009 · Jackson Lab opened its facility in West Sacramento, called The Jackson Laboratory--West, in 2001, and began moving to its new location last ...Missing: campus 2007
  30. [30]
    Sacramento, California Campus - The Jackson Laboratory
    Our Sacramento campus is located 10 miles from downtown Sacramento, with its many popular shops, restaurants and cultural attractions.Missing: 2007 | Show results with:2007
  31. [31]
    Connecticut Campus at The Jackson Laboratory
    Our Farmington campus is home to The Jackson Laboratory for Genomic Medicine. Researchers here focus on human genomics, complementing our long history of ...
  32. [32]
    As its first building opens, Jackson Lab has an eye on expansion
    Oct 2, 2014 · The Jackson Laboratory's new building on the UConn Health campus in Farmington, but some officials at the genomics lab are already thinking about their next ...
  33. [33]
    JAX Genomic Medicine Opens at UConn Health
    Oct 7, 2014 · The atrium of the Jackson Laboratory for Genomic Medicine at the UConn Health campus in Farmington. (Tina Encarnacion/UConn Health Photo).
  34. [34]
    https://www.jax.org/news-and-insights/2025/october/the-jackson-laboratory-acquires-new-york-stem-cell-foundation
  35. [35]
    History Timeline of The Jackson Laboratory
    ... history of The Jackson Laboratory. This timeline showcases the ... Move into new library (2nd floor of C.C. Little Library and Conference Center).
  36. [36]
    Fast Facts - The Jackson Laboratory
    The Jackson Laboratory, a nonprofit biomedical research institution founded in 1929, is dedicated to discovering genomic solutions for diseases and ...Missing: CC Little
  37. [37]
    JAX Research Centers - The Jackson Laboratory
    Mice in Biomedical Research. Areas of Research. Addiction ResearchAging ResearchAlzheimer's and Other DementiasCancerDiabetesEndometriosis Research at JAX.Missing: core | Show results with:core
  38. [38]
    Cancer stem cells, not bulk tumor cells, determine mechanisms of ...
    Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to ... The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. 2 ...
  39. [39]
    The Serreze Lab - The Jackson Laboratory
    The Serreze Lab Investigating the genetic basis of autoimmunity and type 1 diabetes. Our Research Focus Ongoing Serreze laboratory research projects.
  40. [40]
    Type 1 diabetes and viral DNA - The Jackson Laboratory
    Dec 6, 2023 · Type 1 diabetes susceptibility and resistance may involve an ... Jackson Laboratory (JAX) Professor David Serreze, Ph.D. Driver, now an ...
  41. [41]
    Advancing Animal Models of Human Type 1 Diabetes - PubMed - NIH
    Oct 1, 2024 · Multiple rodent models have been developed to study the basis of type 1 diabetes (T1D) ... The Jackson Laboratory, Bar Harbor, Maine 04609, USA ...
  42. [42]
    Lupus Efficacy Studies | The Jackson Laboratory
    The Jackson Laboratory offers efficacy studies in multiple human systemic lupus erythematosus (SLE) models, including the two most commonly used spontaneous ...
  43. [43]
    JAX Center for Aging Research - The Jackson Laboratory
    We focus our diverse expertise in biology and genomics on the problems and disorders associated with aging, employing a systems-wide approach to understand ...
  44. [44]
    JAX Center for Alzheimer's and Dementia Research
    ... models and make these models widely available ... ©2025 The Jackson Laboratory. Choose other country or region, China, Japan.
  45. [45]
    MODEL-AD drives progress for Alzheimer's disease research
    Jul 28, 2024 · The Jackson Laboratory's MODEL-AD Consortium is advancing research by developing mouse models that better represent human Alzheimer's ...
  46. [46]
    Efficient Mouse Colony Management | The Jackson Laboratory
    Cryopreservation is an invaluable tool for cost-effective colony management and forms the foundation of our ability to maintain and distribute over 11,000 ...
  47. [47]
    Genetic Resource Science - The Jackson Laboratory
    Our Repository maintains more than 1,800 strains live as breeding colonies for rapid distribution and over 6,000 others as cryopreserved stock or DNA for ...Genetic Resource Science · Faculty & Staff · Postdoctoral AssociateMissing: early | Show results with:early
  48. [48]
    Model Generation Services (MGS) | The Jackson Laboratory
    JAX's CRISPR/Cas9 Gene Editing Service includes designing and generating reagents, editing genes in mouse zygotes or ES cells, producing and sequencing ...Knock-Outs · Point Mutations · Knock-Ins
  49. [49]
    Three CRISPR Approaches for Mouse Genome Editing
    Feb 15, 2016 · To date, JAX has used CRISPR/Cas9 to successfully generate more than 110 KO models (both indel and deletion) and 69 knock-in models (point ...
  50. [50]
    International Distributors | The Jackson Laboratory
    Charles River supplies some higher-volume, authentic J strains to regional markets in Europe, Scandinavia, the Balkans and parts of Asia.
  51. [51]
    Why JAX® Mice? - The Jackson Laboratory
    As the world's largest mouse model repository, we provide reliable, global access to over 14000 of the most common and unique mouse strains.Missing: achievements | Show results with:achievements
  52. [52]
    Mouse Mutant Resource - The Jackson Laboratory
    We characterize mice carrying spontaneous genetic mutations genetically, genomically and phenotypically prior to making them available to researchers.
  53. [53]
    Mouse Mutant Resource: Available mouse models
    The mouse genomic variants described in the "Mutation" column of this table have been nominated by the Mouse Mutant Resource as most likely causative mutations.
  54. [54]
    The Jackson Laboratory announces acquisition of Charles River ...
    Oct 12, 2021 · The Jackson Laboratory (JAX), a US-based nonprofit biomedical research institution, announced today that it has acquired Charles River Laboratories Japan.
  55. [55]
    Charles River Laboratories Announces Two Divestitures
    Oct 12, 2021 · On October 12 th, the Company completed the sale of its RMS Japan operations to The Jackson Laboratory (JAX) for approximately $63 million in ...
  56. [56]
    Jackson Lab buys Japan-based research animal business for $63M
    Oct 13, 2021 · JAX is buying a Japan-based research animal producer, a subsidiary of a Massachusetts company, to expand the Bar Harbor organization's ...
  57. [57]
    https://www.prnewswire.com/news-releases/the-jackson-laboratory-acquires-new-york-stem-cell-foundation-to-transform-biomedical-research-and-accelerate-precision-therapies-for-patients-302588940.html
  58. [58]
    Introducing a new era of biomedical discovery
    Oct 17, 2025 · Read the official announcement. The Jackson Laboratory has acquired The New York Stem Cell Foundation to transform biomedical research and ...
  59. [59]
    The Jackson Laboratory and LG AI Research partner to pioneer ...
    Mar 10, 2024 · The Jackson Laboratory (JAX) and LG AI Research signed a partnership agreement creating an alliance between JAX's longstanding expertise in ...
  60. [60]
    The Jackson Laboratory and LG AI Research partner to pioneer ...
    Mar 11, 2024 · The Jackson Laboratory (JAX) and LG AI Research signed a partnership agreement creating an alliance between JAX's longstanding expertise in biomedical research ...
  61. [61]
    LG-The Jackson Laboratory (JAX), Jointly Researching AI to Unlock ...
    Mar 11, 2024 · LG and JAX are jointly researching AI for Alzheimer's and cancer, using JAX's data and mice, to improve diagnosis and treatment, and develop AI ...
  62. [62]
    Maine Campus at The Jackson Laboratory
    The Jackson Laboratory has campuses located in Bar Harbor, Ellsworth, Augusta & Portland, Maine.Connecticut · California · Japan
  63. [63]
    Our Economic Impact - The Jackson Laboratory
    Employment has increased to almost 3,000 employees. In 2023, JAX's total operational revenue was $620 million, with approximately $477 million from the ...Missing: staff | Show results with:staff
  64. [64]
    Jackson Lab is expanding to Florida - Bangor Daily News
    Jan 17, 2025 · Overall, Jackson Lab currently has roughly 1,450 employees in Bar Harbor and 250 in Ellsworth, 10 in Augusta, and four in Portland. Aside from ...
  65. [65]
    Japan - The Jackson Laboratory
    NOTE: The Jackson Laboratory Japan is the result of the acquisition of Charles River Laboratories Japan in October, 2021. To ensure a seamless transition ...
  66. [66]
    Global Shipping & Delivery | The Jackson Laboratory
    JAX® Mice are shipped to international destinations via air transport. Airlines and agents are carefully selected based on their ability to control conditions.Missing: distribution | Show results with:distribution
  67. [67]
    Mouse Genome Informatics - The Jackson Laboratory
    MGI is the international database resource for the laboratory mouse, providing integrated genetic, genomic, and biological data to facilitate the study of ...GenesAbout MGIPhenotypes & Mutant AllelesAll Search ToolsGenes and Markers Query Form
  68. [68]
    Jackson Lab looks to adapt to proposed cuts in NIH funding - Mainebiz
    Jul 31, 2025 · If the cuts go through as proposed, he said, it would wipe out $60 million per year in JAX's research funding. “JAX and most other research ...Missing: challenges | Show results with:challenges
  69. [69]
    https://www.jax.org/news-and-insights/2025/october/the-power-of-3
  70. [70]
    How NIH funding impacts local institutions | Business | mdislander.com
    Feb 4, 2025 · Hancock County's largest employer, The Jackson Laboratory, received nearly $82 million from 106 awards from the National Institutes of Health (NIH).<|separator|>
  71. [71]
    Jackson Laboratory - Nonprofit Explorer - ProPublica
    Summary charts: organization finances over time · Revenue. $573M (2023) · Expenses. $577M (2023) · Total Assets. $1.47B (2023) · Total Liabilities. $471M (2023).
  72. [72]
    Jackson Laboratory - Full Filing - Nonprofit Explorer - ProPublica
    Jackson Laboratory ... Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...
  73. [73]
    After two-year peak, Jackson Lab's grant funding drops to ... - Mainebiz
    Jan 2, 2024 · After a two-year peak fueled in part by COVID-related research, the Jackson Laboratory's grant funding in 2023 dropped 30% to an estimated $103 million.<|separator|>
  74. [74]
    What Do Experimental Mice Really Cost? - The Jackson Laboratory
    Mar 6, 2024 · This framework is designed to trim costs, save time, and reduce the number of animals used for colony maintenance and cohort production.
  75. [75]
    Our Medical Impact - The Jackson Laboratory
    JAX professor George Snell, Ph.D., won the 1980 Nobel Prize in Physiology or Medicine for providing an in-depth understanding of the immune system's major ...Missing: notable | Show results with:notable
  76. [76]
    Douglas L. Coleman, Ph.D., Jackson Laboratory Professor Emeritus ...
    Apr 16, 2014 · The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center ...
  77. [77]
    Jackson Lab scientist wins prestigious Lasker Award
    Sep 21, 2010 · The Lasker prize for basic research is shared by Douglas Coleman, 78, of the Jackson Laboratory in Bar Harbor, Maine, and Jeffrey Friedman, 56, ...Missing: Nobel | Show results with:Nobel<|separator|>
  78. [78]
    JAX scientists recognized by International Mammalian Genome ...
    Oct 24, 2023 · Three scientists from The Jackson Laboratory are being recognized for their outstanding achievements by the International Mammalian Genome Society (IMGS).Missing: notable | Show results with:notable
  79. [79]
    Bo Chang, Ph.D. - The Jackson Laboratory
    Conducts research to identify, characterize, and distribute mice with genetically caused eye disorders, including retinitis pigmentosa and achromatopsia.
  80. [80]
    Exploring the nongenetic drivers of acute leukemia drug resistance
    Oct 22, 2023 · ... Jackson Laboratory (JAX) Assistant Professor ... lab studies the molecular mechanisms that regulate leukemia therapy response and survival.
  81. [81]
    Study uncovers molecular “switch” behind chemoresistance in blood ...
    Aug 15, 2025 · JAX scientists are beginning to understand how RNA biology affects resistance to chemotherapy in acute myeloid leukemia.Missing: contributions | Show results with:contributions
  82. [82]
    Researchers are closing in on a mouse model for late-onset ...
    Jul 23, 2024 · Researchers at The Jackson Laboratory are working to create the first strain of mice that's genetically susceptible to late-onset Alzheimer's.
  83. [83]
    New analysis offers most comprehensive roadmap to date for more ...
    Jul 23, 2024 · Research offers first ranking of relative role and significance of every known gene and protein in development of Alzheimer's.Missing: breakthroughs | Show results with:breakthroughs
  84. [84]
    New study uncovers how genes influence retinal aging and brain ...
    Feb 18, 2025 · JAX researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based ...Missing: phenotyping | Show results with:phenotyping
  85. [85]
    Knockout Mouse Project (KOMP) - The Jackson Laboratory
    The Knockout Mouse Project (KOMP) is providing critical tools for understanding gene function and the genetic causes of human diseases.
  86. [86]
    The Jackson Laboratory advances precision medicine with an end ...
    Jun 26, 2025 · Illumina financial solutions. Reagent rental solutions and more that empower researchers to advance. View financing options. Selection Tools.
  87. [87]
    Genomic responses in mouse models poorly mimic human ... - PNAS
    A cornerstone of modern biomedical research is the use of mouse models to explore basic pathophysiological mechanisms, evaluate new therapeutic approaches, ...
  88. [88]
    Enhancing drug discovery using genetically diverse mouse models
    Aug 22, 2024 · Researchers suggest that integrating genetically diverse mouse models with cell-based assays will better replicate human diseases.
  89. [89]
    How many mice and rats are used in U.S. labs? Controversial study ...
    Jan 12, 2021 · More than 111 million mice and rats are used annually in US biomedical research, according to a new study. That represents more than 99% of all lab animals.
  90. [90]
    The Jackson Laboratory - Resource Sharing in Biomedical Research
    Problems that TJL has encountered include the fact that very few mouse strains are commercially viable. This has led other suppliers to develop their own mouse ...
  91. [91]
    Jackson Laboratory denies PETA allegations of mistreating mice
    Mar 2, 2017 · An animal rights organization has filed a federal complaint alleging employees of Jackson Laboratory ignored animal care regulations and created ...
  92. [92]
    [PDF] The Jackson Laboratory - PETA
    Federal documents, dating from November 2006 to December 2016, obtained by PETA from the. National Institutes of Health's Office of Laboratory Animal ...
  93. [93]
    PETA Urges Inspector General to Investigate Botched NIH-Funded ...
    Apr 11, 2024 · PETA is calling for an investigation by the U.S. Department of Health and Human Services (HHS) Office of Inspector General now that the ...Missing: concerns | Show results with:concerns
  94. [94]
    Caruso v. The Jackson Lab. :: 2014 :: Maine Supreme ... - Justia Law
    Caruso subsequently filed a complaint alleging that the Laboratory had taken retaliatory action against her in violation of the Whistleblowers' Protection Act ...
  95. [95]
    Mice and Rats in Laboratories - PETA
    More than 111 million mice and rats are killed in US laboratories every year. They are abused in everything from toxicology tests (in which they are slowly ...
  96. [96]
    JAX Animal Health Program | The Jackson Laboratory
    Our comprehensive Animal Health Program covers importation, diagnostics, clinical medicine, and pathology to ensure:Missing: USDA inspections
  97. [97]
    Incredible: USDA Secretly Curtails Oversight of AAALAC-Accredited ...
    The USDA's new system will exempt accredited research facilities from the full annual compliance inspections mandated by law.
  98. [98]
    [PDF] PHS-Policy-on-Humane-Care-of-Use-of-Laboratory-Animals.pdf
    IACUC members visit and inspect all of the institution's animal facilities at least once every six months using the Guide and PHS Policy as a basis for ...<|separator|>
  99. [99]
    From possible to pivotal - The Jackson Laboratory
    Apr 3, 2017 · The use of mice in biomedical research has contributed dramatically to medical progress. In fact, medicine today is built on a foundation of mice as models of ...
  100. [100]
    [PDF] Animals, quality and the pursuit of relevance.
    Oct 1, 2022 · In response, The Jackson Laboratory faculty and institutional leaders identified key strategies to further address this important issue.Missing: welfare criticisms
  101. [101]
    Jackson Lab Files Federal Complaint, Accusing Chinese University ...
    Sep 21, 2017 · Jackson Lab filed a complaint Monday in federal court in Maine. It's seeking arbitration in its dispute with Nanjing University and affiliated ...Missing: intellectual property
  102. [102]
    Jackson Lab Sues Nanjing University in Dispute over Research Mice
    Sep 25, 2017 · The Jackson Laboratory (JAX) has sued Nanjing University and two affiliated research entities, accusing the Chinese school of breeding and reselling progeny of ...Missing: intellectual property
  103. [103]
    Jackson Lab Cries Foul Over Chinese Mouse Breeding | Maine Public
    Sep 21, 2017 · Chinese researchers are breeding and selling two strains of Jackson Laboratory's famous mice in violation of their contract, according to a federal lawsuit.
  104. [104]
    Maine Lab Accuses Chinese University Of Selling Its Mice - Law360
    Sep 19, 2017 · "It is precisely for these reasons that Jackson must restrict the sale of its mice to uses for research purposes only. Purchasers of [the lab's] ...
  105. [105]
    Jackson Lab files lawsuit against Chinese university over sales of mice
    Sep 22, 2017 · According to the suit, Nanjing University signed a standard purchase agreement for mice with Jackson Lab that allows the university to breed ...Missing: outcome | Show results with:outcome
  106. [106]
    Lawsuit over Jackson Laboratory mice dismissed
    Apr 4, 2018 · Jackson Lab filed a motion Monday to dismiss the suit after Nanjing University agreed to take the issue before an arbitrator and a judge agreed ...Missing: outcome | Show results with:outcome
  107. [107]
    Laboratory files lawsuit over Chinese mouse breeding
    Sep 21, 2017 · The lab says in the lawsuit purchasers of its mice cannot breed, re-sell or distribute any offspring. It claims to have tried to resolve the ...
  108. [108]
    Patents Assigned to The Jackson Laboratory
    The Jackson Laboratory holds patents for cancer image classification, transgenic mouse models, treatments for Charcot-Marie-Tooth disease, and wound healing ...
  109. [109]
    JAX Leap Licensing - The Jackson Laboratory
    NSG Compliment mouse IP rights. Mouse model is subject to U.S. Patent 10,701,911 and all patents issuing therefrom COMPANY is granted a non-exclusive right to ...Missing: strategy | Show results with:strategy
  110. [110]
    General terms and conditions - The Jackson Laboratory
    2.8 “Products” means Mice, Modified Mice, Materials, and/or iPS Cells. ... PATENT, TRADEMARK OR OTHER INTELLECTUAL PROPERTY RIGHTS. JACKSON DOES NOT ...Missing: strategy | Show results with:strategy
  111. [111]
    CRISPR/Cas limited use license - The Jackson Laboratory
    The Jackson Laboratory provides CRISPR-Cas9 technology for creating mouse strains under a license agreement with the Broad Institute, which includes ...Missing: strategy | Show results with:strategy
  112. [112]
    [PDF] C. C. Little Building Name Change Request - Office of the President
    Little was a former head of what became the American Cancer Society. Proctor explains the links: Little believed that cancer was a genetic disease and that only ...
  113. [113]
    Op-Ed: Questioning C.C. Little's legacy - The Michigan Daily
    Apr 17, 2016 · C. C. Little was the president of the American Eugenics Society, which, founded in 1926, was supported by generous donations from the Carnegies.
  114. [114]
    Of lab mice and men - Outside/In
    Aug 24, 2023 · Jackson Laboratory currently has more than 12,000 different strains of lab mice. The lab saves strains through a process called cyro- ...Missing: annually | Show results with:annually
  115. [115]
    [PDF] C.C. Little Hall Name Task Force | Final Report for Committee Review
    Jun 23, 2020 · First, he was a notable figure in the eugenics movement in the. United States, which sanctioned the identification and forced sterilization of ...
  116. [116]
    Jackson Laboratory To Remove Name Of Founder And Eugenicist ...
    eugenics was once widely influential ...
  117. [117]
    Jackson Lab to remove founder's name from conference center
    Jul 20, 2020 · The Bar Harbor laboratory said founder C.C. Little's name is being removed because of his ties to the long-condemned eugenics movement.